Beijing Leadman Biochemistry Co.,Ltd. (SZSE: 300289)
Health Care · Biotechnology · CN
CN¥6.06
+2.02% today · -18.8% 1Y
Beijing Leadman Biochemistry Co.,Ltd. (SZSE: 300289) operates in the Biotechnology industry within the Health Care sector. The company is valued at $491.47M and employs 405 people.
Over the last twelve months the share price has lost 18.8%, trading between 5.19 and 10.41.
Tweenvest scores Beijing Leadman Biochemistry Co.,Ltd. across four factors: quality 70/100, value 27/100, growth 2/100. Its strongest factor is quality.
300289 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $491.47M
- Revenue (TTM)
- $46.78M
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- 0.19
- 52-week high
- CN¥10.41
- 52-week low
- CN¥5.19
- Avg volume (3M)
- —
- Shares outstanding
- 544.01M
- Employees
- 405
- Next earnings
- —
About Beijing Leadman Biochemistry Co.,Ltd.
Beijing Leadman Biochemistry Co.,Ltd. is a prominent entity within the People's Republic of China, specializing in the entire lifecycle – from research and development to manufacturing and distribution – of advanced in vitro diagnostic (IVD) solutions. Its product portfolio encompasses a comprehensive range of biochemical raw materials. This includes critical components like enzymes, coenzymes, antibodies, various buffers, enzyme substrates, culture media, staining reagents, and amino acids. These essential ingredients serve a diverse array of sectors, notably biotechnology, clinical diagnostics, pharmaceutical development, and chemical manufacturing. Beyond raw materials, Leadman also provides specialized biochemistry diagnostic and complementary reagents. Furthermore, the company supplies a sophisticated selection of medical instrumentation. This lineup features the EnigmaML, an automated molecular testing platform designed for both clinical laboratories and various point-of-care settings like clinics and pharmacies. Another key offering is the DiaSys InnovaStar, a compact automated POCT analyzer that delivers laboratory-grade diagnostic accuracy. Customers also benefit from the DiaSys Respons, a versatile random access benchtop analyzer; the CI1000 automatic chemiluminescence immunoassay analyzers; and the IDS-isys, an instrument engineered to boost operational performance and efficiency. Established in 1997, Beijing Leadman Biochemistry maintains its corporate headquarters in Beijing, China.
- ISIN
- CNE100001C22
- Founded
- 1997
- Listed since
- Feb 16, 2012
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Wuhan Hiteck Biological Pharma Co.,LtdSZSE: 300683 | $498.38M | CN¥25.54 | +1.51% |
| Shanghai Bao Pharmaceuticals Co., Ltd.SEHK: 2659 | $497.68M | HK$12.08 | -4.88% |
| Entera Bio Ltd.NasdaqCM: ENTX | $495.19M | $2.51 | -12.24% |
| Allogene Therapeutics, Inc.NasdaqGS: ALLO | $494.05M | $1.43 | -2.05% |
| Guanhao Biotech Co.,Ltd.SZSE: 300238 | $489.37M | CN¥11.95 | -0.33% |
| Bright Minds Biosciences Inc.CNSX: DRUG | $488.45M | CA$73.54 | +4.18% |
| ACRO Biomedical Co., Ltd.TPEX: 6748 | $486.06M | NT$216.00 | -5.26% |
| Qyuns Therapeutics Co., Ltd.SEHK: 2509 | $483.91M | HK$17.00 | +1.37% |
Figures last refreshed Oct 4, 2026.